Dr Mary Wang is Programme Director at Rare Diseases International (RDI) where she leads RDI’s Global Programme on diagnosis, development and access to essential therapies, and oversees RDI’s technical collaboration with the World Health Organization. Mary has 20 years of experience across sectors including biomedical research, research funding, infrastructure, and policy in rare diseases. Prior to joining RDI, Mary worked at Telethon Foundation Italy and supported collaborations in global consortia including the International Rare Diseases Research Consortium (IRDiRC) and in the executive committee of International Consortium for Personalised Medicine (ICPerMed). Mary received her PhD in Cell Biology from University College London, UK.